Avail Medsystems
Peter co-founded Lux Capital with the idea that in order to have the biggest impact on the future, one should support the most scientifically and technologically ambitious ventures. Peter led Lux’s investments in Auris Health (acquired by Johnson & Johnson (JNJ) for up to $6.05 billion, making it one of top 10 VC-backed private M&A transactions of all-time), Lux Research (acquired by Private Equity), Luxtera (acquired by Cisco (CSCO) for $660 million), and SiBEAM (acquired by Silicon Image (SIMG)). Current investments include Avail, Bright Machines, Everspin Technologies (MRAM), Flex Logix, Halo Neuroscience, Matterport, Ripcord, Transphorm, and Vium. In 2003, Peter led the spin-off of Lux Research. As its founding CEO, he helped build Lux Research into the leading emerging-technology research firm. Peter began his career at Lehman Brothers, where he worked in the firm’s top-ranked Equity Research group. He was a Chancellor’s Scholar and graduated cum laude from Syracuse University’s Newhouse School, and was the Founding President of its first venture organization, Future Business Leaders and Entrepreneurs. He has been a guest on CNBC and Bloomberg TV, and speaker at Columbia, Cornell, MIT, Stanford, Yale, and the National Science Foundation.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Avail Medsystems
1 followers
Avail Medsystems is a pioneering medical technology company that provides simple cost-effective solutions that connect procedural healthcare professionals regardless of location. They accomplish this by separating the requirement of physical presence from the ability to collaborate during a procedure. In-person collaboration is costly, requires complex logistics to coordinate and crowds medical procedure rooms limiting the ability of healthcare professionals to support procedures wherever, and whenever, is needed. From an education standpoint, this can add months or even years to the time required to train all providers on the latest medical device technologies. Avail aims to democratize access to clinical and procedural expertise by removing physical, economic and logistical barriers. Its Procedural TelemedicineTM solution addresses these challenges by enabling on-the-go collaboration with any remote healthcare professional. Remote users have the ability to access views from multiple high definition pan-tilt-zoom cameras and external imaging equipment, split the screens to view inputs side by side, annotate, freeze frames and more. Avail's portable, fully integrated, Avail Consoles allow the treating physician and other local healthcare professionals to see everything the remote user displays in real-time. This capability underpins a fully interactive collaborative experience for both the remote user and the treating physician.